Historical record - last NADAC effective date: 9/22/2021
Product Information
AMLODIPINE-BENAZEPRIL 10-40 MG is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.1939 per EA under NDC 68180076001. Its NADAC has been published 411 times since Nov 28, 2013.
FDA first approved this application on Feb 5, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10; 40 mg/1; mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180076001
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/22/2021
Active Ingredients
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078466FDA Approved
2/5/2010
TE Code
AB
On Market Since
7/5/2011
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-BENAZEPRIL 10-40 MG has been published 411 times since Nov 28, 2013, and over the history we have for it it has declined 67.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1939 per EA |
|---|---|
| All-time high | $0.5899 (Dec 11, 2013) |
| All-time low | $0.1355 (Apr 17, 2019) |
| Median price | $0.2722 |
| Average price | $0.2956 |
| Largest weekly change | -22.4% (Aug 22, 2018) |
| Weeks tracked | 411 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
+3.7%
All
-67.1%
Last surveyed Oct 6, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 21% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMLODIPINE-BENAZEPRIL 10-40 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-BENAZEPRIL 10-40 MG, manufactured by Lupin Pharmaceuticals Inc., is $0.1939 per EA (NDC 68180076001), effective Oct 6, 2021.
How has the price of AMLODIPINE-BENAZEPRIL 10-40 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-BENAZEPRIL 10-40 MG has declined 67.1%. It has been tracked across 411 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-BENAZEPRIL 10-40 MG?
Since Nov 28, 2013, the NADAC for AMLODIPINE-BENAZEPRIL 10-40 MG has ranged from a low of $0.1355 (Apr 17, 2019) to a high of $0.5899 (Dec 11, 2013), with a median of $0.2722 per EA.
Are there cheaper alternatives to AMLODIPINE-BENAZEPRIL 10-40 MG?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AMLODIPINE-BENAZEPRIL 10-40 MG, is $0.1536 per EA — about 21% below AMLODIPINE-BENAZEPRIL 10-40 MG.
Who manufactures AMLODIPINE-BENAZEPRIL 10-40 MG?
AMLODIPINE-BENAZEPRIL 10-40 MG (NDC 68180076001) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.